Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of miR-199a-3p in preparation of medicine for resisting hepatitis B virus

A mir-199a-3p, 1.mir-199a-3p technology, applied in antiviral agents, drug combinations, pharmaceutical formulations, etc., can solve problems such as incomplete elucidation of the mechanism of action

Inactive Publication Date: 2011-01-26
TIANJIN MEDICAL UNIV
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the mechanism of HBV persistent infection and the mechanism of interaction between host and HBV have not been fully elucidated

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of miR-199a-3p in preparation of medicine for resisting hepatitis B virus
  • Application of miR-199a-3p in preparation of medicine for resisting hepatitis B virus
  • Application of miR-199a-3p in preparation of medicine for resisting hepatitis B virus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] 1. Cell Culture

[0024] HepG2 2.2.15 and HEK293 cell lines were cultured in DMEM and MEM-α (GIBCO, USA) basal medium respectively, both mediums were supplemented with 10% fetal bovine serum, 20mM HEPES, 2mM glutamine, 100 units / ml penicillin and 100 μg / ml streptomycin, all cells were placed in 5% CO 2 In a 37°C incubator, subculture every 2-3 days.

[0025] 2. Cell Transfection

[0026] The 2'methoxy (2'-OMe) modified antisense oligonucleotide (ASO) that is completely complementary to human mature miRNA was synthesized by IDT, and the cells were prepared in 10 4Each well was inoculated in a 96-well plate, and the next day, the cells were transfected with 50nM miRNA 2'-OMe-ASO or 5ng / μL miRNA expression vector with Lipofectamine 2000, and each group of experiments was done in 3 replicate wells, according to the laboratory Conventional methods and refer to instructions. After 48 hours, the culture medium was changed, and after 24 hours, the cell supernatant was coll...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of miR-199a-3p in the preparation of a medicine for resisting hepatitis B virus (HBV). MiR-199a-3p is a nucleotide sequence described in the sequence table SEQ ID NO:1. Experimental results show that miR-199a-3p can effectively reduce the expression of HBsAg, but can not influence the proliferation of HepG2 2.2.15 cells. Real time PCR (Polymerase Chain Reaction) to HBV DNA quantitatively displays that miR-199a-3p inhibits the replication of the virus. Bioinformatic analysis shows that the HBsAg coding area has a binding site of miR-199a-3p; fluorescence report carrier experiments verify the influence of miR-199a-3p on HBV transcription products; and meanwhile, real time PCR and western blot are used for further verifying that miR-199a-3p has inhibition action on the expression of HBsAg. The results imply that miR-199a-3p plays an important role in regulating and controlling the replication of HBC and can be prepared into a medicine for resisting HBV.

Description

technical field [0001] The invention belongs to the technical field of biomedical materials. It relates to a use of miRNA. Background technique [0002] miRNA is an endogenous small RNA of about 22 nucleotides, expressed in almost all known eukaryotic cells, regulates gene expression through the miRNA-mediated RNA silencing pathway, and regulates cell proliferation, differentiation and apoptosis. At the same time, miRNA also plays an important role in regulating virus replication and viral gene expression. miR-122 can increase the replication of hepatitis C virus (Jopling CL, et al. Modulation of hepatitis C virus RNA abundance by aliver-specific MicroRNA. Science 2005; 309, 1577-1581.), while miR-32 inhibits primate Translation of foamy virus type 1 (PFV-1) (Lecellier CH,. et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308, 557-560.). miRNA can also regulate the interaction between HIV and host T cells, affecting latent or persistent ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K48/00A61K31/7105C12N15/113A61P1/16A61P31/20
Inventor 汤华章广玲李怡璇王芳刘涛万海英李欣刘民
Owner TIANJIN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com